Short and Long-Term Outcomes in Hirschsprung Disease: Are the Syndrome-Associated Patients Really Doing Worse?
Journal
Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
medline:
30
10
2023
pubmed:
27
7
2023
entrez:
27
7
2023
Statut:
ppublish
Résumé
Given the lack of data to help caregivers in the follow-up of Hirschsprung disease (HD), this study aimed to compare the functional outcomes of isolated Hirschsprung disease (I-HD) to syndrome-associated Hirschsprung disease (SA-HD) at 1, 3, 5, and 10 years. A retrospective chart review of patients diagnosed with HD between January 1990 and May 2021 at our pediatric center was performed to collect data on patient characteristics, investigations, and treatments. Ninety-five patients were identified, of whom 76 were included in the study. SA-HD is defined as a syndrome known to be associated with HD or cognitive impairment. Patient characteristics were comparable between groups ( P > 0.05). There were 52 patients with I-HD and 24 with SA-HD. The patients median age was 9 days at diagnosis and 1.5 month at surgery. SA-HD patients became bowel continent at a significantly older age (mean age 8.43 vs 4.94 years, P = 0.0471) and received more bowel continence medications. At 5 years, SA-HD patients requiring ≥2 medications for bowel continence represented 54.5% versus 11.1% of I-HD patients ( P = 0.009). Lastly, SA-HD patients had urinary incontinence at a significantly older age ( P = 0.0136, 5 years). Clinicians should be aware that SA-HD patients are more prone to bladder dysfunction and became bowel continent at an older age than I-HD patients. They need more and prolonged bowel management medications, and other important complications need to be addressed in patient care. These results should prompt a longer follow-up period for these patients, especially in SA-HD.
Identifiants
pubmed: 37496148
doi: 10.1097/MPG.0000000000003896
pii: 00005176-990000000-00451
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
592-596Informations de copyright
Copyright © 2023 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Kenny SE, Tam PK, Garcia-Barcelo M. Hirschsprung’s disease. Semin Pediatr Surg. 2010;19:194–200.
Anderson JE, Vanover MA, Saadai P, Stark RA, Stephenson JT, Hirose S. Epidemiology of Hirschsprung disease in California from 1995 to 2013. Pediatr Surg Int. 2018;34:1299–303.
Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45:1–14.
Moore SW, Tshifularo N. Hirschsprung’s disease in the neurologically challenged child. Int J Adolesc Med Health. 2011;23:223–7.
Moore SW. The contribution of associated congenital anomalies in understanding Hirschsprung’s disease. Pediatr Surg Int. 2006;22:305–15.
Friedmacher F, Puri P. Hirschsprung’s disease associated with Down syndrome: a meta-analysis of incidence, functional outcomes and mortality. Pediatr Surg Int. 2013;29:937–46.
Meinds RJ, van der Steeg AFW, Sloots CEJ, et al. Long-term functional outcomes and quality of life in patients with Hirschsprung’s disease. Br J Surg. 2019;106:499–507.
Thakkar HS, Bassett C, Hsu A, et al. Functional outcomes in Hirschsprung disease: a single institution’s 12-year experience. J Pediatr Surg. 2017;52:277–80.
Niramis R, Watanatittan S, Anuntkosol M, et al. Quality of life of patients with Hirschsprung’s disease at 5–20 years post pull-through operations. Eur J Pediatr Surg. 2008;18:38–43.
Catto-Smith AG, Trajanovska M, Taylor RG. Long-term continence after surgery for Hirschsprung’s disease. J Gastroenterol Hepatol. 2007;22:2273–82.
Ambartsumyan L, Patel D, Kapavarapu P, et al. Evaluation and Management of Postsurgical Patient With Hirschsprung Disease Neurogastroenterology & Motility Committee: Position Paper of North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2023;76:533–46.
Hedbys J, Hasserius J, Granéli C, Arnbjörnsson E, Hagelsteen K, Stenström P. Children with Hirschsprung’s disease and syndromes with cognitive dysfunction: manifestations, treatment, and outcomes. Surg J (N Y). 2019;5:e103–9.
Davidson JR, Kyrklund K, Eaton S, et al. Outcomes in Hirschsprung’s disease with coexisting learning disability. Eur J Pediatr. 2021;180:3499–507.
Mrad FCC, Figueiredo AA, Bessa J Jr, Bastos Netto JM. Prolonged toilet training in children with Down syndrome: a case-control study. J Pediatr (Rio J). 2018;94:286–92.
Dreher T, Wolter-Warmerdam K, Holland S, Katz T, Patel L. Toilet training in children and adolescents with Down syndrome. J Dev Behav Pediatr. 2022;43:e381–9.
Niemczyk J, von Gontard A, Equit M, Medoff D, Wagner C, Curfs L. Incontinence in persons with Down syndrome. Neurourol Urodyn. 2017;36:1550–6.
Nasr A, Grandpierre V, Sullivan KJ, Wong CA, Benchimol EI. Long-term outcomes of patients surgically treated for Hirschsprung disease. J Can Assoc Gastroenterol. 2021;4:201–6.